PC

Peter L. Collins

US US Dept of Health & Human Services: 20 patents #17 of 3,044Top 1%
IB Institute For Research In Biomedicine: 4 patents #19 of 73Top 30%
SF SUNY Research Foundation: 3 patents #119 of 1,165Top 15%
CO Codagenix: 3 patents #2 of 14Top 15%
TA The United States Of America: 3 patents #9 of 521Top 2%
UM University Of Maryland: 1 patents #209 of 857Top 25%
UP University Of Maryland, College Park: 1 patents #377 of 1,056Top 40%
WU Washington University: 1 patents #704 of 1,596Top 45%
NI NIH: 1 patents #22 of 259Top 9%
PC Pharmacia & Upjohn Company: 1 patents #359 of 713Top 55%
RC Rush-Presbyterian-St. Lukes Medical Center: 1 patents #18 of 59Top 35%
RC Rush University Medical Center: 1 patents #38 of 137Top 30%
Abbott: 1 patents #3,441 of 5,431Top 65%
UH University Of North Carolina At Chapel Hill: 1 patents #769 of 1,688Top 50%
📍 Kensington, MD: #1 of 263 inventorsTop 1%
🗺 Maryland: #137 of 35,612 inventorsTop 1%
Overall (All Time): #35,275 of 4,157,543Top 1%
63
Patents All Time

Issued Patents All Time

Showing 26–50 of 63 patents

Patent #TitleCo-InventorsDate
9624475 Genetically stable live attenuated respiratory syncytial virus vaccine and its production Cindy L. Luongo, Ursula Buchholz, Brian R. Murphy 2017-04-18
9034343 Attenuated human parainfluenza virus, methods and uses thereof Mario H. Skiadopoulos, Brian R. Murphy, Sheila Nolan 2015-05-19
8367074 Recovery of recombinant human parainfluenza virus type 2 (HYPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens Mario H. Skiadopoulos, Brian R. Murphy 2013-02-05
7951383 Attenuated parainfluenza virus (PIV) vaccines Brian R. Murphy, Mario H. Skiadopoulos 2011-05-31
7919301 Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from CDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens Mario H. Skiadopoulos, Brian R. Murphy 2011-04-05
7846455 Attenuated chimeric respiratory syncytial virus Brian R. Murphy, Stephen S. Whitehead 2010-12-07
7842798 Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines Ursula Buchholz, Brian R. Murphy, Stephen S. Whitehead, Christine Krempl 2010-11-30
7829102 Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines Ursula Buchholz, Brian R. Murphy, Stephen S. Whitehead, Christine Krempl 2010-11-09
7820181 Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens Mario H. Skiadopoulos, Brian R. Murphy 2010-10-26
7820182 Production of attenuated, human-bovine chimeric respiratory syncytial viruses for use in immunogenic compositions Ursula Buchholz, Brian R. Murphy, Stephen S. Whitehead, Christine Krempl 2010-10-26
7744902 Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal genes Christine Krempl, Brian R. Murphy, Ursula Buchholz, Stephen S. Whitehead 2010-06-29
7709007 Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences Brian R. Murphy, Stephen S. Whitehead, Alexander Bukreyev, Katalin Juhasz, Michael N. Teng 2010-05-04
7704491 Recombinant human metapneumovirus and its use Stephane Biacchesi, Ursula Buchholz, Mario H. Skiadopoulos, Brian R. Murphy 2010-04-27
7704509 Recovery of recombinant human parainfluenza virus type 1 (HPIV1) from cDNA and use of recombinant HPIV1 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens Brian R. Murphy, Mario H. Skiadopoulos, Jason T. Newman 2010-04-27
7662397 Respiratory syncytial virus vaccines expressing protective antigens from promoter-proximal genes Christine Krempl, Brian R. Murphy, Ursula Buchholz, Stephen S. Whitehead 2010-02-16
7632508 Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines Alexander C. Schmidt, Mario H. Skiadopoulos, Brian R. Murphy, Jane E. Bailly, Anna P. Durbin 2009-12-15
7622123 Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines Mario H. Skiadopoulos, Brian R. Murphy, Alexander C. Schmidt 2009-11-24
7589180 Specific binding proteins and uses thereof Lloyd J. Old, Terrance Grant Johns, Con Panousis, Andrew Scott, Christoph Renner +7 more 2009-09-15
7585667 Negative strand RNA virus replicon Paul D. Olivo, Mark E. Peeples 2009-09-08
7485440 Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2 Brian R. Murphy, Alison Bermingham 2009-02-03
7465794 Polynucleotides encoding recombinant respiratory syncytial viruses expressing immune modulatory molecules Alexander Bukreyev, Brian R. Murphy, Stephen S. Whitehead 2008-12-16
7314631 Use of recombinant live-attenuated parainfluenza virus (PIV) as a vector to protect against disease caused by PIV and respiratory syncytial virus (RSV) Brian R. Murphy, Anna P. Durbin, Mario H. Skiadopoulos, Tao Tao 2008-01-01
7250171 Construction and use of recombinant parainfluenza viruses expressing a chimeric glycoprotein Tao Tao, Mario H. Skiadopoulos, Brian R. Murphy 2007-07-31
7244558 Production of novel Newcastle disease virus strains from cDNAs and improved live attenuated Newcastle disease vaccines Siba K. Samal 2007-07-17
7208161 Production of attenuated parainfluenza virus vaccines from cloned nucleotide sequences Brian R. Murphy, Anna P. Durbin, Mario H. Skiadopoulos, Tao Tao 2007-04-24